Biotech & pharma
Gene linked to development of glaucoma
02 Sep 2014
New tool to probe cancer’s molecular make-up
02 Sep 2014
Evolution used similar molecular toolkits to shape flies worms and humans
01 Sep 2014
Although separated by hundreds of millions of years of evolution, humans share ancient patterns of gene expression with flies and worms, according to a massive Yale-led analysis of genomic data
Researchers uncover secrets of newborn neurons
01 Sep 2014
How to rejuvenate ageing immune cells
30 Aug 2014
Fully functional immune organ grown in mice from lab-created cells
28 Aug 2014
Scientists have for the first time grown a complex, fully functional organ from scratch in a living animal by transplanting cells that were originally created in a laboratory. The advance could in future aid the development of ‘lab-grown’ replacement organs
Researchers grow ‘seed’ of spinal cord tissue in a dish
27 Aug 2014
The discovery could lead to a new way of studying degenerative conditions such as spinal muscular atrophy, which affects the nerve cells in the spinal column
Cancer leaves a common fingerprint on DNA
26 Aug 2014
New analysis reveals tumour weaknesses
23 Aug 2014
Synthetic molecule makes cancer self-destruct
22 Aug 2014
Study tracks blood cell gene variant
13 Aug 2014
Stem cells show promise for stroke in pilot study
09 Aug 2014
A stroke therapy using stem cells extracted from patients' bone marrow has shown promising results in the first trial of its kind in humans.
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
